ADMA
Conviction 54HealthcareScan · Thu, Sep 24, 2026Adma Biologics, Inc. (ADMA) closed at $9.51 (-1.96%) on Sep 24, 2026. Price is above its 50-day and below its 200-day moving average. RSI(14) 53, RS Rating 25, -53.3% from its 52-week high, -46.8% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ADMA
Insider activity
SEC Form 4 transactions in ADMA · open-market 3 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Kestenberg-Messina Kaitlin M. COO and SVP, Compliance · Common Stock · 2026-07-24 | Tax | 3.18K | $27K | 2026-07-24 | 2026-07-28 |
Kohler Terry CFO and Treasurer · Common Stock · 2026-07-16 | Grant | 85.13K | — | 2026-07-16 | 2026-07-17 |
Kohler Terry CFO and Treasurer · Stock Option (Right to Buy) · 2026-07-16 | Grant | 136.36K | — | 2026-07-16 | 2026-07-17 |
Grossman Jerrold B Director · Common Stock · 2026-05-27 | Other | — | — | 2026-05-27 | 2026-05-28 |
Grossman Jerrold B Director · Common Stock · 2026-05-27 | Buy | 6.4K | $51K | 2026-05-27 | 2026-05-28 |
Grossman Jerrold B Director · Common Stock · 2026-05-12 | Other | — | — | 2026-05-12 | 2026-05-14 |
Grossman Jerrold B Director · Common Stock · 2026-05-12 | Buy | 12.5K | $100K | 2026-05-12 | 2026-05-14 |
Grossman Jerrold B Director · Common Stock · 2026-05-11 | Other | — | — | 2026-05-11 | 2026-05-12 |
Grossman Jerrold B Director · Common Stock · 2026-05-11 | Buy | 12.5K | $100K | 2026-05-11 | 2026-05-12 |
SEC filings
EDGAR filings in ADMA · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.